Loading…
Oramed Pharmaceuticals Inc. is projected to rise to $4.73 by 2027, a +19% move from its current price of $3.98. ORMP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.85 | $3.98 | $4.11 | -0.01% |
| May 30 | $3.80 | $3.98 | $4.17 | -0.02% |
| May 31 | $3.76 | $3.98 | $4.21 | -0.03% |
| Jun 1 | $3.73 | $3.98 | $4.25 | -0.03% |
| Jun 2 | $3.70 | $3.98 | $4.28 | -0.04% |
| Jun 3 | $3.67 | $3.98 | $4.31 | -0.05% |
| Jun 4 | $3.65 | $3.98 | $4.34 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.65 | $3.98 | $4.34 | -0.06% |
| Week 2 | $3.52 | $3.98 | $4.49 | -0.12% |
| Week 3 | $3.42 | $3.97 | $4.61 | -0.18% |
| Week 4 | $3.34 | $3.97 | $4.72 | -0.24% |
| Week 5 | $3.27 | $3.97 | $4.81 | -0.30% |
| Week 6 | $3.21 | $3.97 | $4.90 | -0.37% |
| Week 7 | $3.16 | $3.96 | $4.98 | -0.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oramed Pharmaceuticals Inc. is a healthcare company that engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes.
The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Oramed Pharmaceuticals Inc. (ORMP) trades as a healthcare stock with a current price of $3.99. The company has a market capitalization of $161.38M and is ranked 3976 by market cap.
The near-term outlook contains a clear forecast path with the 2026 average price at $3.99 and a rising trend through the following years, supported by bullish sentiment starting in 2027.
From 2027 onward, the forecast shows continued upside, with 2027 averaging $4.84 (ROI 21.3) and 2028 averaging $6.75 (ROI 69.2). The 2029 average is $8.51 (ROI 113.3) and 2030 is $9.10 (ROI 128.1), with ongoing bullish sentiment through 2031–2050. By 2040 the average is projected at $21.21 (ROI 431.6) and by 2050 at $49.08 (ROI 1130.1).
A major floor 20.4% below — a decisive break under it would weaken the trend.
The nearest floor, 4.0% below — buyers have tended to step in here.
The nearest ceiling, 18.8% above — a clean break opens room to run.
A major ceiling 27.8% above — clearing it would confirm fresh momentum.
Key ORMP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ORMP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.13 | Sell | $4.11 | Sell |
| MA 10 | $4.32 | Sell | $4.19 | Sell |
| MA 20 | $4.19 | Sell | $4.16 | Sell |
| MA 50 | $3.85 | Buy | $3.92 | Buy |
| MA 100 | $3.62 | Buy | $3.62 | Buy |
| MA 200 | $3.04 | Buy | $3.24 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.28 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -54.93 | Neutral |
| Williams %R (14) | -91.46 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -2.69 | Sell |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 8.54 | Buy |
| TRIX (15) | 0.58 | Buy |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 32.50 | Neutral |
| Momentum (10) | -0.47 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 3.96 | Buy |
| ADX (14) | 20.43 | Sell |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is bullish. RSI14 is 50, and the 50-day simple moving average is $3.83 while the 200-day simple moving average is $3.02, indicating a mild upward tilt in momentum. The near-term layout is supported by a $3.79 level and facing resistance near $4.73.
The 30-day price range spans from $3.18 to $5.00, providing a defined corridor for near-term movements. With bullish sentiment in play, traders may monitor how the price reacts around the $3.79 support and $4.73 resistance as conditions evolve.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.91 | $3.98 | $5.72 | 0% | Neutral | |
| $3.68 | $4.73 | $6.48 | +19% | Neutral | |
| $4.78 | $6.35 | $9.06 | +60% | Bullish | |
| $5.81 | $7.93 | $11.69 | +99% | Bullish | |
| $6.13 | $8.58 | $13.01 | +116% | Bullish | |
| $6.20 | $8.88 | $13.79 | +123% | Bullish | |
| $6.32 | $9.24 | $14.66 | +132% | Bullish | |
| $7.03 | $10.49 | $16.96 | +164% | Bullish | |
| $7.77 | $11.83 | $19.48 | +197% | Bullish | |
| $9.22 | $14.30 | $23.93 | +259% | Bullish | |
| $10.98 | $18.52 | $33.23 | +365% | Bullish | |
| $21.65 | $42.45 | $84.18 | +967% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.91 | $3.98 | $4.70 | +0.00% |
| June 2026 | $3.40 | $4.01 | $4.86 | +0.81% |
| July 2026 | $3.31 | $3.95 | $4.86 | -1.59% |
| August 2026 | $3.44 | $4.13 | $5.14 | +4.50% |
| September 2026 | $3.59 | $4.34 | $5.46 | +5.17% |
| October 2026 | $3.54 | $4.30 | $5.45 | -0.94% |
| November 2026 | $3.49 | $4.27 | $5.46 | -0.70% |
| December 2026 | $3.62 | $4.44 | $5.72 | +4.09% |
Click any year to see its month-by-month ORMP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ORMP to range from $2.91 to $5.72 through 2026. The $3.98 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ORMP price prediction for 2027 points to an average of $4.73 (low $3.68, high $6.48) — a potential gain of +19% on today's $3.98. Price action looks broadly range-bound.
In 2028, ORMP is projected to trade between $4.78 and $9.06, averaging $6.35 — a potential gain of +60% from today's $3.98. That is up +34% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Oramed Pharmaceuticals Inc.'s 2029 outlook centres on $7.93, within a $5.81 to $11.69 range. That is up +25% on the projected 2028 average. That marks a +99% change versus current levels. Momentum favours further upside here.
By 2030, ORMP could reach as high as $13.01, with a base case around $8.58 and support toward $6.13 — roughly +116% from $3.98. Buyers look set to stay in control over this stretch.
Expect ORMP to range from $6.20 to $13.79 through 2031. The $8.88 average target implies a +123% move from current prices. That is up +4% on the projected 2030 average. Momentum favours further upside here.
The ORMP price prediction for 2032 points to an average of $9.24 (low $6.32, high $14.66) — a potential gain of +132% on today's $3.98. Buyers look set to stay in control over this stretch.
In 2033, ORMP is projected to trade between $7.03 and $16.96, averaging $10.49 — a potential gain of +164% from today's $3.98. That is up +14% on the projected 2032 average. Momentum favours further upside here.
Oramed Pharmaceuticals Inc.'s 2034 outlook centres on $11.83, within a $7.77 to $19.48 range. That is up +13% on the projected 2033 average. That marks a +197% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ORMP could reach as high as $23.93, with a base case around $14.30 and support toward $9.22 — roughly +259% from $3.98. Momentum favours further upside here.
Expect ORMP to range from $10.98 to $33.23 through 2040. The $18.52 average target implies a +365% move from current prices. That is up +30% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ORMP price prediction for 2050 points to an average of $42.45 (low $21.65, high $84.18) — a potential gain of +967% on today's $3.98. Momentum favours further upside here.
Investing $1,000 in ORMP today (≈ 251.256281 ORMP) could be worth
$10,666.82
+$9,666.82 (+967%) by 2050 · US Dollar
Based on the average projected ORMP price of $42.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ORMPwould be worth at today's price.
$1,000 invested in ORMP on May 27, 2025 (≈ 467.289697 ORMP) would be worth
$1,859.81
+$859.81 (+86.0%) today · 1.86× · US Dollar
Based on a ORMP entry price of $2.14 vs. today's $3.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.28 | $929.91 | -7.0% |
| 1 month ago | $4.11 | $968.37 | -3.2% |
| 3 months ago | $3.43 | $1,160.35 | +16.0% |
| 6 months ago | $2.85 | $1,396.49 | +39.6% |
| 1 year ago | $2.14 | $1,859.81 | +86.0% |
| All time (5.0y) ago | $11.67 | $341.05 | -65.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ORMP forecast.
Our base-case forecast reaches $8.00 around 2030.
Implied market cap at $8.00: $327.41M
The multi-year forecast points to substantial upside, with bullish sentiment beginning in 2027 and extending through 2050. The 2030 average price is $9.10 with a 128.1 ROI, the 2040 average is $21.21 with a 431.6 ROI, and the 2050 average is $49.08 with a 1130.1 ROI. This trajectory reflects a clear long-term upside path from the 2026 base of $3.99 toward much higher averages over time.
In this horizon, the forecast also indicates sustained bullish sentiment across the later years, underscoring expectations of continued appreciation. While these numbers illustrate meaningful potential, they are estimates and not guarantees, and actual results may differ due to market and company-specific factors.
Tap a question to reveal the answer.
The 2030 forecast shows an avg of $9.10, with a min of $6.42 and a max of $13.98; the associated ROI is 128.1 and the sentiment is BULLISH.
The forecast points to bullish sentiment from 2027 onward with rising averages, including an avg of $9.10 in 2030 and $49.08 by 2050, with ROI values reaching 128.1 in 2030 and 1130.1 by 2050. These are estimates, not guarantees.
Yes. The 2050 forecast shows an avg of $49.08 and a max of $99.60, indicating a potential to surpass $50 in the higher end of the range.
The near-term picture is bullish with RSI 14 at 50. The SMA50 is $3.83 and the SMA200 is $3.02. Support is at $3.79 and resistance at $4.73, with a 30-day range of $3.18 to $5.00.
Current price is $3.99 and market cap is $161.38M, with a market-cap rank of 3976.
Oramed Pharmaceuticals Inc. Community Discussion
0Share your Oramed Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.